Francisco de Asís Bartol-Puyal, María Chacón González, Borja Arias-Peso, Damián García Navarro, Silvia Méndez-Martínez, María Pilar Ruiz Del Tiempo, Luis Sáez Comet, Luis Pablo Júlvez
PURPOSE: To assess vision-related quality of life (VRQoL) in patients with systemic lupus erythematosus (SLE) under treatment with hydroxychloroquine (HCQ), and to find the influencing factors. METHODS: Cross-sectional study enrolling SLE patients for less than ten years (Group 1), SLE patients for more than ten years (Group 2), and healthy controls (Group 3). SLE patients should be under treatment with HCQ but without ophthalmological affection. Schirmer test, best-corrected visual acuity (BCVA), axial length (AL) with optical biometry, and swept-source optical coherence tomography-angiography (OCTA) Triton (Topcon) were performed...
February 24, 2024: Healthcare (Basel, Switzerland)